InvestorsHub Logo
Followers 0
Posts 178
Boards Moderated 0
Alias Born 12/04/2013

Re: None

Tuesday, 08/16/2016 4:01:57 AM

Tuesday, August 16, 2016 4:01:57 AM

Post# of 8495
PFE TRIAL TERMINATED

Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase
This study has been terminated.
(The study was terminated early on July 8, 2016 due to business priorities regarding study execution.)
Sponsor:
Pfizer
Collaborator:
Halozyme Therapeutics
Information provided by (Responsible Party):
Pfizer
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News